Enanta Pharmaceuticals
ENTA
#8126
Rank
C$0.51 B
Marketcap
C$17.82
Share price
3.31%
Change (1 day)
11.04%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$0.27 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30C$0.30 B-10.29%
2024-09-30C$0.33 B0.47%
2023-09-30C$0.33 B347.87%
2022-09-30C$74.5 M49.24%
2021-09-30C$49.92 M22.82%
2020-09-30C$40.65 M12.29%
2019-09-30C$36.19 M37.2%
2018-09-30C$26.38 M-14.79%
2017-09-30C$30.96 M107.42%
2016-09-30C$14.92 M13.73%
2015-09-30C$13.12 M73.24%
2014-09-30C$7.57 M12.82%
2013-09-30C$6.71 M-17.12%
2012-09-30C$8.1 M88.72%
2011-09-30C$4.29 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$165.47 B 59,189.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$114.15 B 40,802.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$200.98 B 71,913.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$10.22 B 3,564.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$125.17 B 44,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$93.10 B 33,257.68%๐Ÿ‡บ๐Ÿ‡ธ USA